RapidAI

About:

RapidAI empowers clinicians to make accurate diagnostic and treatment decisions for stroke and aneurysm patients.

Twitter/X: rapidai

Top Investors: Vista Credit Partners, Lennertz & Co.

Description:

RapidAI empowers clinicians to make accurate diagnostic and treatment decisions for stroke and aneurysm patients. RapidAI's platform uses artificial intelligence to create advanced images from non-contrast CT, CT Angiography, CT perfusion, and MRI diffusion and perfusion scans.

Total Funding Amount:

$100M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Menlo Park, California, United States

Founded Date:

2011-01-01

Founders:

Gregory Albers, Karim Karti

Number of Employees:

101-250